Axe Rescheek - 1st November Joomlaxe Templates

Newsflash

LIFT Cancer Trial Starting in China
A new clinical trial based on Dr. Zheng Cui's granulocyte technology is starting at Beijing's 304 Hospital. Go to The LIFT Cancer Treatment Trial Site for more information.

Case Studies

Stories of Success

Cancer News

Care Centers

Liver Cancer
Liver Cancer Treatment Print

Liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer related deaths worldwide.

Liver cancer refers to the growth of malignant tumors in liver tissue. There are two different types of primary liver cancer, heptoma and cholangiocarcinoma. Heptoma or hepatocullular carcinoma (HCC) is the cancer that arises from hepatocytes, the main liver cells. Cholangiocarcinoma, or bile duct cancer, starts in the bile duct cells and grows along the bile ducts in sheets or lines.


Traditional Treatments

Possible traditional treatments are surgery (including liver transplants), chemotherapy, and radiotherapy.

 

Cutting-edge therapies available in China Cancer Center (CCC) for liver cancer may consist of:
For early stage liver cancer
   Surgery
   CIK-DC immunotherapy
Features:
   1. Radical cure for early stage liver cancer.
   2. Efficient prevention of recurrence and metastasis.
   3. No toxicity or side effects to human body.  
   4. Quick recovery after treatments.
   5. Quality of life is improved with an enhanced immune system.


For advanced liver cancer:
   Cryoablation
   Gene therapy
   Antiangionesis therapy
   Interventional therapy
   CIK-DC immunotherapy
Features:
   1. Minimally invasive cryoablation, with little harm to normal function, little pain to patients, small incision wounds, and a quick recovery.
   2. Cryoablation can enhance the therapeutic effects of TACE on large liver tumors.
   3. CIK-DC cell immunotherapy, can improve the immune function against the tumor, which significantly extends survival time with a good quality of life.
   4. No toxicity or side effects. The cutting edge therapies for advanced stage liver cancer offered by CCC removes the lesions as well as improves the immune system. It is a promising treatment to improve overall quality of life and extend survival time.

 

For recurrence and metastatic liver cancer
   Cryoablation
   Gene therapy
   Antiangionesis therapy
   Interventional therapy
   CIK-DC immunotherapy

Metastatic liver cancer is secondary liver cancer. Together with recurrence, metastatic liver cancer usually happens in advanced stages, when the patient is too weak for another surgery or for chemotherapy. Combination of Cryoablation, interventional therapy, and CIK-DC cell immunotherapy is a good systematic treatment for recurrence and metastatic liver cancer.

Read more about cases studies

Colon Cancer w/Liver Metastasis-N/A-70 yrs-Holland-July 2006

Liver Cancer - N/A - 59 yrs - Netherland - Jan. 2005

Liver Cancer - Ms. Yang - 61 yrs - China - April 2003 

Last Updated on Wednesday, 21 July 2010 11:33
 
Liver Cancer -59 yrs - Netherlands Print


Sex: Male



Age: 59 years

Country: Netherlands

Diagnosis: Patient had a large liver tumor with metastases and abdominal pain after several unsuccessful chemotherapy regimens in the Netherlands

Therapy: In January 2005, a combination of Gene therapy, TACE, CIK-DC immunotherapy, and traditional Chinese medicine were utilized.



Results: After two months of the treatment, including interventional therapy, the large tumor became mostly necrotic and shrank. Meanwhile, the enlarged lymph nodes in the groin and abdominal pain disappeared.
Last Updated on Wednesday, 21 July 2010 12:13
 
Liver Cancer - Mr. Tan - 58 yrs - China - June 2005 Print


Name: Mr Tan
Gender: Male
Age: 58

Diagnosis: Primary liver cancer, with multiple tumors

Before Treatment: The patient had accepted radiotherapy, chemotherapy and 5 TACE treatments (transcatheter arterial chemo embdization). The cancer recurred, with one large tumor and two small ones detected.

Treatment: In June 2005, the patient accepted a combined therapy of TACE therapy, Cryoablation and CIK (cytokine-induced killer cell) immunotherapy.

Post-therapy status: In December 2005, the tumors had mostly disappeared. The patient has survived for three more years and is alive today.

 

Fig 1.: The image shows three visible lesions in the liver.

 

 

 

 

Fig 2.: Six months after treatment, the lesions are no longer visible.

 
Last Updated on Thursday, 09 July 2009 10:40
 
Liver Cancer - Ms. Yang - 61 yrs - China - April 2003 Print


Name: Ms. Yang
Gender: Female
Age: 61

Diagnosis: Primary liver cancer, tumor size 6×7cm

Pre-therapy status: tumor still remained after chemotherapy and four TACE treatments.

Treatment: In April 2003, the patient accepted a combined therapy of TACE, Cryoablation , and CIK cell immunotherapy. The tumor disappeared completely within four months and the patient survived for five more years.

 Scanned image
Fig 1.: The CT scan shows a liver tumor of 6x7cm, prior to treatment
 
Fig 2.: This CT scan shows no tumor four months later.

 
Last Updated on Thursday, 09 July 2009 10:40
 


Copyright © Place your copyright here.
XHTML and CSS valid
Joomla free templates Designed by joomlaxe